Castle Biosciences, Inc.

CSTL

$34.36

Name : Castle Biosciences, Inc.

Sector : Healthcare

Industry: Diagnostics & Research

Mark. Cap: $1,058,916,544.00

EPSttm : -0.76

Castle Biosciences, Inc.

$34.36

1.09%

$0.37

CSTL — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

6.98

Margin Of Safety %

-24

Put/Call OI Ratio

0.91

EPS Next Q Diff

-0.26

EPS Last/This Y

-1.11

EPS This/Next Y

0.31

Price

33.96

Target Price

48.2

Analyst Recom

1.1

Performance Q

11.26

Upside

-179.3%

Beta

0.96

Ticker: CSTL

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-13	CSTL	32.9	0.22	999.99	477
2026-10-14	CSTL	33.17	0.22	999.99	477
2026-10-15	CSTL	33.8	0.22	999.99	477
2026-10-16	CSTL	31.98	0.22	0.00	477
2026-10-19	CSTL	32.17	0.38	0.50	155
2026-10-20	CSTL	33.06	0.38	0.50	155
2026-10-21	CSTL	34.38	0.39	0.00	157
2026-10-22	CSTL	33.17	0.39	0.00	157
2026-10-23	CSTL	33.14	0.39	0.00	157
2026-10-26	CSTL	33.25	0.39	0.00	157
2026-10-27	CSTL	34.5	0.39	999.99	158
2026-10-28	CSTL	36.63	0.39	0.50	159
2026-10-29	CSTL	38.52	0.40	0.00	164
2026-10-30	CSTL	37.06	0.35	0.00	180
2026-11-02	CSTL	34.89	0.35	4.00	181
2026-11-03	CSTL	35.22	0.35	2.00	181
2026-11-04	CSTL	35.8	0.38	0.60	186
2026-11-05	CSTL	34.1	0.40	1.00	190
2026-11-06	CSTL	32.51	0.90	0.25	1690
2026-11-09	CSTL	34.44	0.91	999.99	1688
2026-11-10	CSTL	34.36	0.91	999.99	1688
2026-11-11	CSTL	33.96	0.91	999.99	1688
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-13	CSTL	32.88	-100.0	-	-1.27
2026-10-14	CSTL	33.08	-100.0	-	-1.27
2026-10-15	CSTL	33.79	-100.0	-	-1.27
2026-10-16	CSTL	32.03	-100.0	-	-1.26
2026-10-19	CSTL	32.18	-100.0	-	-1.26
2026-10-20	CSTL	32.18	-100.0	-	-1.26
2026-10-21	CSTL	33.12	-100.0	-	-1.26
2026-10-22	CSTL	33.09	-100.0	-	-1.26
2026-10-23	CSTL	33.18	-100.0	-	-1.26
2026-10-26	CSTL	33.26	-100.0	-	-1.26
2026-10-27	CSTL	34.42	-100.0	-	-1.26
2026-10-28	CSTL	36.67	-100.0	-	-1.26
2026-10-29	CSTL	38.51	-100.0	-	-1.26
2026-10-30	CSTL	37.14	-100.0	-	-1.26
2026-11-02	CSTL	34.93	-100.0	-	-1.26
2026-11-03	CSTL	35.16	-100.0	-	-1.26
2026-11-04	CSTL	35.81	-100.0	-	-1.26
2026-11-05	CSTL	34.09	-100.0	-	-1.26
2026-11-06	CSTL	32.49	-100.0	-	-1.25
2026-11-09	CSTL	34.44	-100.0	-	-1.25
2026-11-10	CSTL	34.36	-100.0	-	-1.25
2026-11-11	CSTL	33.96	-100.0	-	-1.25
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-13	CSTL	-34.22	-0.98	6.68
2026-10-14	CSTL	-34.44	-0.98	6.68
2026-10-15	CSTL	-34.67	-0.98	6.68
2026-10-16	CSTL	-34.67	-0.98	6.68
2026-10-19	CSTL	-34.67	-0.35	6.68
2026-10-20	CSTL	-34.78	-0.35	6.68
2026-10-21	CSTL	-34.78	-0.35	6.68
2026-10-22	CSTL	-35.78	-0.35	6.68
2026-10-23	CSTL	-35.78	-0.35	6.68
2026-10-26	CSTL	-35.49	-0.61	6.68
2026-10-27	CSTL	-35.50	-0.61	6.74
2026-10-28	CSTL	-35.50	-0.61	6.74
2026-10-29	CSTL	-35.72	-0.61	6.74
2026-10-30	CSTL	-35.72	-0.61	6.74
2026-11-02	CSTL	-36.16	-0.66	6.74
2026-11-03	CSTL	-36.16	-0.66	6.74
2026-11-05	CSTL	-37.11	-0.66	6.74
2026-11-06	CSTL	-37.11	-0.66	6.74
2026-11-09	CSTL	-36.91	-5.75	6.68
2026-11-10	CSTL	-36.91	-5.75	6.68
2026-11-11	CSTL	-36.91	-5.75	6.98
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-0.13

Avg. EPS Est. Current Quarter

-0.35

Avg. EPS Est. Next Quarter

-0.39

Insider Transactions

-36.91

Institutional Transactions

-5.75

Beta

0.96

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

25.96

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

37.8

Max Drawdown 5-Year %

-78.5

Target Price

48.2

P/E

Forward P/E

PEG

P/S

2.78

P/B

2.19

P/Free Cash Flow

264.52

EPS

-0.77

Average EPS Est. Cur. Y

-1.25

EPS Next Y. (Est.)

-0.94

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6.1

Relative Volume

0.88

Return on Equity vs Sector %

-31.2

Return on Equity vs Industry %

-16.5

EPS 1 7Days Diff

EPS 1 30Days Diff

0.02

EBIT Estimation

◆ CSTL Healthcare

$33.99

📉

Swing / Pullback

Buy the dip on strong trends

N/A

WEAK

Trend

6/20

Pullback

19/25

Volume

7/15

Valuation

12/20

TP/AR

3/10

Options

3/10

RSI

48.5

Range 1M

34.3%

Sup Dist

0.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

3/25

Growth

16/30

Estimates

4/20

Inst/Vol

2/15

Options

4/10

EPS Yr

-3%

EPS NY

27%

52W%

61.6%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟡 HOLD +2.6% upside

Quality

6/30

Valuation

3/30

Growth

12/25

Stability

8/10

LT Trend

0/5

Upside

+2.6%

Quality

MoS

-24%

CSTL — P/E HistoricalDiagnostics & Research

Castle Biosciences, Inc.

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 1048

Castle Biosciences, Inc., a molecular diagnostics company, provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), atopic dermatitis (AD), and uveal melanoma. The company offers DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test that predicts the likelihood of a positive sentinel lymph node and the risk of metastasis for patients with invasive cutaneous melanoma; TissueCypher, a risk stratification spatialomics test to predict future development of high-grade dysplasia and/or esophageal cancer in patients with non-dysplastic, indefinite dysplasia, and low-grade dysplasia BE; AdvanceAD-Tx, a non-invasive GEP test which is designed to guide systemic treatment selection for patients aged 12 years and older with moderateto-severe AD; DecisionDx-SCC, a GEP test for cutaneous squamous cell carcinoma; and MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions. It also provides DecisionDx-UM, a risk stratification GEP test that predicts the risk of metastasis for patients with uveal melanoma. The company offers its products to dermatology and gastroenterology markets. The company was incorporated in 2007 and is headquartered in Friendswood, Texas.

CSTL

Latest News

—

Caricamento notizie per CSTL…

stock quote shares CSTL – Castle Biosciences Inc. Stock Price stock today

news today CSTL – Castle Biosciences Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CSTL – Castle Biosciences Inc. yahoo finance google finance

stock history CSTL – Castle Biosciences Inc. invest stock market

stock prices CSTL premarket after hours

ticker CSTL fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CSTL

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y